ISS, Glass Lewis, and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split
businesswire.com
news
2022-10-19 00:00:00

October 19, 2022 07:00 AM Eastern Daylight Time PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the three leading, independent proxy advisory firms - Institutional Shareholder Services (ISS), Glass Lewis and Co, LLC, and Egan-Jones & Co - all recommend that shareholders vote 'For' Proposal 2, Reverse Stock Split, at Acorda's Special Meeting of Stockholders, scheduled for November 4, 2022.



'We appreciate the confirmation of the need for and urgency of this proposal,' said John P.
